Key Points
- Yoshiyuki Aikawa, SBC's CEO, sold 465,000 shares on April 28 at $3.02 for $1.404M and has completed two earlier large sales (3.1M on Apr 21 and 4.4229M on Mar 6), trimming his stake by 0.59% while still holding 78,839,460 shares (~$238.1M).
- SBC trades with a market cap of $338.5M and a P/E of 6.73; it reported $0.14 EPS (beats) but missed revenue at $39.57M, and analysts have a consensus Hold rating with an average price target of $8.50.
SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 465,000 shares of SBC Medical Group stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $3.02, for a total value of $1,404,300.00. Following the completion of the sale, the chief executive officer directly owned 78,839,460 shares of the company's stock, valued at approximately $238,095,169.20. This trade represents a 0.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Yoshiyuki Aikawa also recently made the following trade(s):
- On Tuesday, April 21st, Yoshiyuki Aikawa sold 3,100,000 shares of SBC Medical Group stock. The shares were sold at an average price of $3.02, for a total transaction of $9,362,000.00.
- On Friday, March 6th, Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock. The stock was sold at an average price of $2.12, for a total transaction of $9,376,548.00.
SBC Medical Group Price Performance
SBC opened at $3.30 on Thursday. The firm has a 50-day moving average price of $3.91 and a 200-day moving average price of $3.99. SBC Medical Group Holdings Incorporated has a twelve month low of $2.97 and a twelve month high of $5.75. The company has a quick ratio of 3.74, a current ratio of 3.78 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $338.50 million, a price-to-earnings ratio of 6.73 and a beta of 0.99.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings results on Friday, March 27th. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.01. SBC Medical Group had a net margin of 29.37% and a return on equity of 20.76%. The company had revenue of $39.57 million for the quarter, compared to analysts' expectations of $45.19 million. Equities analysts expect that SBC Medical Group Holdings Incorporated will post 0.47 EPS for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on SBC shares. BTIG Research began coverage on SBC Medical Group in a report on Friday, March 6th. They issued a "buy" rating and a $8.00 price target for the company. Weiss Ratings reiterated a "sell (d+)" rating on shares of SBC Medical Group in a research note on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $8.50.
Check Out Our Latest Analysis on SBC
Hedge Funds Weigh In On SBC Medical Group
Several hedge funds have recently bought and sold shares of the company. Goldman Sachs Group Inc. bought a new stake in SBC Medical Group during the 4th quarter worth approximately $49,000. Russell Investments Group Ltd. boosted its holdings in SBC Medical Group by 292.0% in the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company's stock valued at $51,000 after purchasing an additional 8,771 shares during the period. Nuveen LLC bought a new position in SBC Medical Group in the 4th quarter valued at $53,000. Wells Fargo & Company MN grew its position in shares of SBC Medical Group by 195.1% during the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company's stock valued at $54,000 after purchasing an additional 8,348 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of SBC Medical Group during the 2nd quarter valued at $64,000. Hedge funds and other institutional investors own 60.82% of the company's stock.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.
The company's primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
